Anti-CD38 immunotherapy treatment for multiple myeloma
22 Nov 2021
Anti-CD38 immunotherapy treatment for multiple myeloma
Optimal use of asparaginase for acute lymphoblastic leukaemia
Practical applications on new data of genetic ALL subtypes
Triple class refractory multiple myeloma
Tobacco control in Africa
Palliative care in Africa
What to look forward to at AORTIC 2021
AORTIC 2021: Goals of AORTIC
Nivolumab plus chemotherapy or ipilimumab vs chemotherapy as first-line treatment for gastric cancers
Pathogenesis of colon adenocarcinoma in Kerala, India
Trastuzumab deruxtecan vs trastuzumab emtansine in patients with HER2+ metastatic breast cancer
ESMO 2021: PARPi data and their role in mono/combination therapies